2 leading ASX 200 shares to buy that could keep outperforming in 2023: fund manager

These two names could keep delivering outperformance.

| More on:
Two older male friends using tech to record their run.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • WAM Leaders has identified two of its top picks in its portfolio
  • Medibank’s sell-off was “overdone” according to the fund manager
  • Brambles is benefiting from price increases

The fund manager Wilson Asset Management (WAM) has recently identified some S&P/ASX 200 Index (ASX: XJO) shares that it owns (or owned) in one of its biggest portfolios.

WAM operates several listed investment companies (LICs), including WAM Capital Limited (ASX: WAM) and WAM Research Limited (ASX: WAX).

There's also one called WAM Leaders Ltd (ASX: WLE) that looks at the larger companies on the ASX, often referred to as ASX blue-chip shares.

WAM says WAM Leaders actively invests in the highest quality Australian companies. But does WAM have a good reputation for picking stocks?

The WAM Leaders portfolio has delivered gross returns (before fees, expenses, and taxes) of 14.8% per annum since its inception in May 2016. This compares to the S&P/ASX 200 Accumulation Index's average return of 8.8% over the same period.

These are two ASX 200 shares that the WAM Leaders investment team picked out.

Medibank Private Limited (ASX: MPL)

Created with Highcharts 11.4.3Medibank Private Ltd PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

WAM Leaders revealed that it added Medibank Private shares to its portfolio late last year after the "cyber breach incident" and subsequent earnings guidance downgrade.

The large Australian private health insurer suffered from a share price decline. But, after the negative news flow "dissipated" and the share price still hadn't recovered, the WAM Leaders team thought that the negative sentiment was "overdone".

WAM noted that the result released in February 2023 was "strong", with health insurance claims remaining "subdued" because the healthcare system is "capacity constrained" due to the lack of staff, while industry growth remains "buoyant", driven by net migration and new participants domestically.

The fund manager also pointed out that the ASX 200 share noted its policyholder numbers had "stabilised" and the outlook has "improved for the year ahead."

Brambles Limited (ASX: BXB)

Created with Highcharts 11.4.3Brambles PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

The WAM investment team described Brambles as a business that specialises in the pooling of unit-load equipment. The ASX share has been in the WAM Leaders portfolio for over 12 months.

WAM said that Brambles' half-year result in February was "strong", which was driven by "significant pricing increases."

Brambles is expecting its cash flow to remain in outflow this year. But, it upgraded its earnings guidance and noted cash flow pressures will "ease into next year as capital expenditure slows."

The fund manager finished its bullish case on the ASX 200 share with the following:

Going forward, we expect profitability to be a key focus, with pricing increases in a tight market continuing while pallet efficiencies improve. The impact of pallet destocking as the economy slows should help bring more balance to the pallet market globally.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

Man sitting in a plane seat works on his laptop.
Opinions

Expert reveals 2 ASX stocks to sell — and 1 is a recent IPO

Toby Grimm from Baker Young shares his insights.

Read more »

An analyst wearing a dark blue shirt and glasses sits at his computer with his chin resting on his hands as he looks at the CBA share price movement today
Opinions

Expert's verdict on 3 ASX 200 shares (2 have doubled in value and the other has lost 29%)

Two of these stocks were the best performers of their sectors in FY25. Should you buy, hold, or sell?

Read more »

A male investor sits at his desk pondering at his laptop screen with a piece of paper in his hand.
Opinions

Where I'd invest in ASX shares ahead of the likely RBA rate cut

These stocks look too good to miss.

Read more »

Person pretends to types on laptop drawn in sand.
Opinions

I sold one of my oldest ASX 200 shares last week. Here's why

Why would I sell one of my longest-held stocks?

Read more »

Broker analysing the share price.
Materials Shares

Buy, hold, or sell? Broker's verdict on 3 ASX 200 materials shares

Materials was one of four market sectors that weakened in overall value in FY25.

Read more »

A person sitting at a desk smiling and looking at a computer.
Technology Shares

3 ASX 200 tech shares to buy in July: Experts

The ASX tech sector delivered outstanding returns for investors in FY25.

Read more »

A group of executives sit in front of computer screens in a darkened room while a colleague stands giving a presentation with a share price graphic lit up on the wall
Opinions

2 ASX 200 large-cap shares that this fundie is cashing in after phenomenal growth

Shaw and Partners portfolio manager James Gerrish says he knows this will be an 'unpopular call'.

Read more »

Woman and man calculating a dividend yield.
Opinions

Buy or bail? Fundie's verdict on 2 ASX 300 shares

Stuart Bromley of Medallion Financial Group provides his insights.

Read more »